{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:44:22Z","timestamp":1789695862499,"version":"4.0.1"},"reference-count":112,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T00:00:00Z","timestamp":1557187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01006","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T04:42:05Z","timestamp":1557204125000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":47,"title":["Prevention of Pediatric Respiratory Syncytial Virus Lower Respiratory Tract Illness: Perspectives for the Next Decade"],"prefix":"10.3389","volume":"10","author":[{"given":"Sofia S.","family":"Aranda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando P.","family":"Polack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,5,7]]},"reference":[{"key":"B1","unstructured":"RSV Vaccine and mAb Snapshot-PATH Vaccine Resource Library2018"},{"key":"B2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1542\/peds.102.3.531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group","volume":"102","year":"1998","journal-title":"Pediatrics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"eaaj1879","DOI":"10.1126\/sciimmunol.aaj1879","article-title":"Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors","volume":"1","author":"Gilman","year":"2016","journal-title":"Sci Immunol."},{"key":"B4","volume-title":"Respiratory Syncytial Virus Infection (RSV)","author":"Schweitzer","year":"2019"},{"key":"B5","first-page":"1086","article-title":"Knipe PMH.","volume-title":"Fields Virology, 6th ed. Respiratory Syncytial Virus","author":"David","year":"2013"},{"key":"B6","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3389\/fimmu.2014.00466","article-title":"Immunity to RSV in early-life","volume":"5","author":"Lambert","year":"2014","journal-title":"Front. Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.vaccine.2016.09.030","article-title":"The innate immune response to RSV: Advances in our understanding of critical viral and host factors","volume":"35","author":"Sun","year":"2017","journal-title":"Vaccine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.tim.2013.08.006","article-title":"Pathogen recognition receptor crosstalk in respiratory syncytial virus sensing: a host and cell type perspective","volume":"21","author":"Marr","year":"2013","journal-title":"Trends Microbiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e02202","DOI":"10.1128\/JVI.02202-17","article-title":"Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control","volume":"92","author":"Hillyer","year":"2018","journal-title":"J Virol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nm.1894","article-title":"Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease","volume":"15","author":"Delgado","year":"2009","journal-title":"Nat Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"11034","DOI":"10.1038\/s41598-018-29456-w","article-title":"Type I interferon potentiates IgA immunity to respiratory syncytial virus infection during infancy","volume":"8","author":"Hijano","year":"2018","journal-title":"Sci Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.coviro.2017.03.012","article-title":"Vaccine development for respiratory syncytial virus","volume":"23","author":"Graham","year":"2017","journal-title":"Curr Opin Virol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-3-642-38919-1_4","article-title":"Structure and function of respiratory syncytial virus surface glycoproteins","volume":"372","author":"McLellan","year":"2013","journal-title":"Curr Topics Microbiol Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.immuni.2018.01.005","article-title":"Infants infected with respiratory syncytial virus generate potent neutralizing antibodies that lack somatic hypermutation","volume":"48","author":"Goodwin","year":"2018","journal-title":"Immunity."},{"key":"B15","doi-asserted-by":"publisher","first-page":"16271","DOI":"10.1038\/nmicrobiol.2016.271","article-title":"A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein","volume":"2","author":"Mousa","year":"2017","journal-title":"Nat Microbiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e0165108","DOI":"10.1371\/journal.pone.0165108","article-title":"Epidemiology and clinical presentations of respiratory syncytial virus subgroups A and B detected with multiplex real-time PCR","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS ONE"},{"key":"B17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/infdis\/160.2.185","article-title":"Prevalence of respiratory syncytial virus subgroups over six consecutive outbreaks: 1981-1987","volume":"160","author":"Hendry","year":"1989","journal-title":"J Infect Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1128\/CMR.11.3.430","article-title":"Respiratory syncytial virus vaccines","volume":"11","author":"Dudas","year":"1998","journal-title":"Clin Microbiol Rev."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2018.07.012","article-title":"Cytokines and CD8 T cell immunity during respiratory syncytial virus infection","author":"Schmidt","year":"2018","journal-title":"Cytokine"},{"key":"B20","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1084\/jem.20020781","article-title":"A role for immune complexes in enhanced respiratory syncytial virus disease","volume":"196","author":"Polack","year":"2002","journal-title":"J Exp Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1128\/CVI.00609-15","article-title":"Brief history and characterization of enhanced respiratory syncytial virus disease","volume":"23","author":"Acosta","year":"2015","journal-title":"Clin Vac Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e1004757","DOI":"10.1371\/journal.ppat.1004757","article-title":"RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsets","volume":"11","author":"Knudson","year":"2015","journal-title":"PLoS Pathog"},{"key":"B24","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/oxfordjournals.aje.a120957","article-title":"Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population","volume":"89","author":"Chin","year":"1969","journal-title":"Am J Epidemiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/oxfordjournals.aje.a120954","article-title":"An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine","volume":"89","author":"Kapikian","year":"1969","journal-title":"Am J Epidemiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/oxfordjournals.aje.a120956","article-title":"Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine","volume":"89","author":"Fulginiti","year":"1969","journal-title":"Am J Epidemiol"},{"key":"B27","unstructured":"A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants via Maternal Immunization2018"},{"key":"B28","unstructured":"Positive Topline Data From Phase 2 Older Adult Trial and Path Forward for RSV F Vaccine Programs2018"},{"key":"B29","unstructured":"Novavax Announces Topline Results from Phase 3 PrepareTM Trial of ResVax\u2122 for Prevention of RSV Disease in Infants via Maternal Immunization2019"},{"key":"B30","unstructured":"2017"},{"key":"B31","unstructured":"Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A) in Healthy Women2018"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/infdis\/jiy065","article-title":"Safety and immunogenicity of 3 formulations of an investigational respiratory syncytial virus vaccine in nonpregnant women: results from 2 phase 2 trials","volume":"217","author":"Beran","year":"2018","journal-title":"J Infect Dis."},{"key":"B33","unstructured":"Pfizer Begins a Phase 1\/2 Study to Evaluate Respiratory Syncytial Virus (RSV) Vaccine2018"},{"key":"B34","unstructured":"Describe the Safety and Immunogenicity of a RSV Vaccine in Healthy Adults2018"},{"key":"B35","unstructured":"The Action-Packed Search for Stability: A Breakthrough in the Fight Against RSV2019"},{"key":"B36","unstructured":"Respiratory Syncytial Virus Vaccine Enters Clinical Testing2018"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e0186854","DOI":"10.1371\/journal.pone.0186854","article-title":"Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus","volume":"12","author":"Sastry","year":"2017","journal-title":"PLoS ONE"},{"key":"B38","first-page":"592","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume-title":"Science","author":"McLellan","year":"2013"},{"key":"B39","unstructured":"A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Preterm Infants2018"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e01714","DOI":"10.1128\/AAC.01714-16","article-title":"Safety, tolerability, and pharmacokinetics of MEDI8897, the respiratory syncytial virus prefusion F-targeting monoclonal antibody with an extended half-life, in healthy adults","volume":"61","author":"Griffin","year":"2017","journal-title":"Antimicrob Agents Chemother."},{"key":"B41","doi-asserted-by":"publisher","first-page":"6147","DOI":"10.1128\/AAC.01285-13","article-title":"A novel investigational Fc-modified humanized monoclonal antibody, motavizumab-YTE, has an extended half-life in healthy adults","volume":"57","author":"Robbie","year":"2013","journal-title":"Antimicrob Agents Chemotherap."},{"key":"B42","doi-asserted-by":"publisher","first-page":"23514","DOI":"10.1074\/jbc.M604292200","article-title":"Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn)","volume":"281","author":"Dall'Acqua","year":"2006","journal-title":"J Biol Chem."},{"key":"B43","unstructured":"Safety Tolerability and Pharmacokinetics of MK-1654 in Infants2018"},{"key":"B44","unstructured":"Study to Evaluate the Efficacy and Safety of Suptavumab (REGN2222) for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants2018"},{"key":"B45","doi-asserted-by":"publisher","first-page":"7372","DOI":"10.1016\/j.vaccine.2007.08.014","article-title":"The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines","volume":"25","author":"Wright","year":"2007","journal-title":"Vaccine."},{"key":"B46","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/978-3-642-38919-1_13","article-title":"Live-attenuated respiratory syncytial virus vaccines","volume":"372","author":"Karron","year":"2013","journal-title":"Curr Topics Microbiol Immunol."},{"key":"B47","unstructured":"Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children2019"},{"key":"B48","unstructured":"Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children2018"},{"key":"B49","unstructured":"Evaluating the Infectivity Safety and Immunogenicity of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV \u0394NS2\/\u03941313\/I1314L or RSV 276 in RSV-Seronegative Infants and Children 6 to 24 Months of Age2019"},{"key":"B50","unstructured":"Infectivity Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (D46\/NS2\/N\/\u0394M2-2-HindIII) in RSV-Seronegative Infants and Children 6 to 24 Months of Age2019"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.1016\/S1473-3099(18)30292-5","article-title":"The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates","volume":"18","author":"Mazur","year":"2018","journal-title":"Lancet Infect Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"312ra175","DOI":"10.1126\/scitranslmed.aac8463","article-title":"A gene deletion that up-regulates viral gene expression yields an attenuated RSV vaccine with improved antibody responses in children","volume":"7","author":"Karron","year":"2015","journal-title":"Sci Transl Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1089\/hum.2013.235","article-title":"Adenovirus-based vaccines for fighting infectious diseases and cancer: progress in the field","volume":"25","author":"Majhen","year":"2014","journal-title":"Human Gene Therapy."},{"key":"B54","unstructured":"A Study to Evaluate The Safety, Tolerability, Immunogenicity of an Investigational RSV Vaccine Candidate (Ad26,.RSV.preF) in Adults 18 to 50 Years of Age, RSV-Seropositive Toddlers 12 to 24 Months of Age.2018"},{"key":"B55","unstructured":"RSV Investigational Vaccine in RSV-Seropositive Infants Aged 12 to 23 Months2018"},{"key":"B56","unstructured":"A Study to Assess Safety Tolerability and Immunogenicity of the Live Attenuated hRSV Vaccine rBCG-N-hRSV (EVA-VRS01)2018"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1080\/21645515.2017.1334026","article-title":"A safe and efficient BCG vectored vaccine to prevent the disease caused by the human respiratory syncytial virus","volume":"13","author":"Rey-Jurado","year":"2017","journal-title":"Hum Vaccines Immunotherapeut."},{"key":"B58","doi-asserted-by":"publisher","first-page":"20822","DOI":"10.1073\/pnas.0806244105","article-title":"Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG","volume":"105","author":"Bueno","year":"2008","journal-title":"Proc Nat Acad Sci."},{"key":"B59","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1128\/JVI.66.12.7444-7451.1992","article-title":"Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB\/c mice is abrogated by depletion of CD4+ T cells","volume":"66","author":"Connors","year":"1992","journal-title":"J Virol"},{"key":"B60","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.4049\/jimmunol.151.4.2032","article-title":"Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus","volume":"151","author":"Graham","year":"1993","journal-title":"J Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"34108","DOI":"10.1038\/srep34108","article-title":"Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus","volume":"6","author":"Killikelly","year":"2016","journal-title":"Sci Rep."},{"key":"B62","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/77506","article-title":"Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles","volume":"6","author":"Polack","year":"2000","journal-title":"Nat Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nri3804","article-title":"Dynamics of B cells in germinal centres","volume":"15","author":"De Silva","year":"2015","journal-title":"Nat Rev Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.4049\/jimmunol.1701217","article-title":"Human Extrafollicular CD4(+) Th Cells Help Memory B Cells Produce Igs","volume":"201","author":"Kim","year":"2018","journal-title":"J Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.immuni.2015.12.004","article-title":"A Temporal switch in the germinal center determines differential output of memory b and plasma cells","volume":"44","author":"Weisel","year":"2016","journal-title":"Immunity"},{"key":"B66","doi-asserted-by":"publisher","first-page":"5316","DOI":"10.1016\/j.vaccine.2014.07.064","article-title":"Genetic polymorphisms of CXCR5 and CXCL13 are associated with non-responsiveness to the hepatitis B vaccine","volume":"32","author":"Duan","year":"2014","journal-title":"Vaccine"},{"key":"B67","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.coi.2013.04.003","article-title":"Dynamic regulation of Bcl6 in follicular helper CD4 T (Tfh) cells","volume":"25","author":"Choi","year":"2013","journal-title":"Curr Opin Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.immuni.2010.12.012","article-title":"Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion","volume":"34","author":"Morita","year":"2011","journal-title":"Immunity"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1542\/peds.112.6.1442","article-title":"Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections","volume":"112","year":"2003","journal-title":"Pediatrics"},{"key":"B70","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1016\/j.vaccine.2017.05.045","article-title":"A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age","volume":"35","author":"August","year":"2017","journal-title":"Vaccine"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1056\/NEJM199311183292102","article-title":"Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group","volume":"329","author":"Groothuis","year":"1993","journal-title":"N Engl J Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1086\/314523","article-title":"Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein","volume":"178","author":"Malley","year":"1998","journal-title":"J Infect Dis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"e0119509","DOI":"10.1371\/journal.pone.0119509","article-title":"A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models","volume":"10","author":"Lambert","year":"2015","journal-title":"PLoS ONE"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.vaccine.2013.11.032","article-title":"A recombinant anchorless respiratory syncytial virus (RSV) fusion (F) protein\/monophosphoryl lipid A (MPL) vaccine protects against RSV-induced replication and lung pathology","volume":"32","author":"Blanco","year":"2014","journal-title":"Vaccine"},{"key":"B75","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1172\/JCI75183","article-title":"TLR4 genotype and environmental LPS mediate RSV bronchiolitis through Th2 polarization","volume":"125","author":"Caballero","year":"2015","journal-title":"J Clin Invest"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1542\/peds.110.2.e20","article-title":"Respiratory syncytial virus infection in Navajo and White Mountain Apache children","volume":"110","author":"Bockova","year":"2002","journal-title":"Pediatrics"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/S1473-3099(15)00247-9","article-title":"Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial","volume":"15","author":"O'Brien","year":"2015","journal-title":"Lancet Infect Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1056\/NEJMoa1211917","article-title":"Respiratory syncytial virus and recurrent wheeze in healthy preterm infants","volume":"368","author":"Blanken","year":"2013","journal-title":"N Engl J Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1093\/infdis\/jix031","article-title":"Interference between respiratory syncytial virus and human rhinovirus infection in infancy","volume":"215","author":"Achten","year":"2017","journal-title":"J Infect Dis."},{"key":"B80","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0140-6736(98)10321-5","article-title":"Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years","volume":"354","author":"Stein","year":"1999","journal-title":"Lancet"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1164\/rccm.200804-579OC","article-title":"Evidence of a causal role of winter virus infection during infancy in early childhood asthma","volume":"178","author":"Wu","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1038\/nm.2896","article-title":"Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma","volume":"18","author":"Krishnamoorthy","year":"2012","journal-title":"Nat Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1542\/peds.2013-0982","article-title":"Effect of palivizumab prophylaxis on subsequent recurrent wheezing in preterm infants","volume":"132","author":"Yoshihara","year":"2013","journal-title":"Pediatrics"},{"key":"B84","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jaci.2010.05.026","article-title":"The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children","volume":"126","author":"Sim\u00f5es","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/S2213-2600(18)30232-7","article-title":"RSV prevention in infancy and asthma in later life - Authors' reply","volume":"6","author":"Scheltema","year":"2018","journal-title":"Lancet Respir Med"},{"key":"B86","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1164\/rccm.201609-1812OC","article-title":"Palivizumab prophylaxis in preterm infants and subsequent recurrent wheezing. six-year follow-up study","volume":"196","author":"Mochizuki","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"B87","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1097\/INF.0000000000001167","article-title":"The impact of respiratory syncytial virus disease prevention on pediatric asthma","volume":"35","author":"Caballero","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"B88","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study","volume":"390","author":"Shi","year":"2017","journal-title":"Lancet"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1542\/peds.2014-2151","article-title":"Respiratory syncytial virus-associated mortality in hospitalized infants and young children","volume":"135","author":"Byington","year":"2015","journal-title":"Pediatrics"},{"key":"B90","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1164\/rccm.201603-0658OC","article-title":"Mortality due to respiratory syncytial virus. burden and risk factors","volume":"195","author":"Geoghegan","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"B91","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/infdis\/jiy517","article-title":"Mortality in children in the community associated with acute respiratory infections","volume":"219","author":"Caballero","year":"2018","journal-title":"J Infect Dis."},{"key":"B92","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"B93","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/tropej\/49.6.327","article-title":"Case fatality proportions and predictive factors for mortality among children hospitalized with severe pneumonia in a rural developing country setting","volume":"49","author":"Djelantik","year":"2003","journal-title":"J Trop Pediatr"},{"key":"B94","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0140-6736(00)82011-5","article-title":"WHO Collaborative Study team on the role of breastfeeding on the prevention of infant mortality","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/S0022-3476(73)80453-6","article-title":"Host resistance factors in human milk","volume":"82","author":"Goldman","year":"1973","journal-title":"J Pediatr"},{"key":"B96","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1023\/A:1015830907632","article-title":"The nasal mucociliary clearance: relevance to nasal drug delivery","volume":"8","author":"Schipper","year":"1991","journal-title":"Pharm Res"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1093\/infdis\/jit828","article-title":"The source of respiratory syncytial virus infection in infants: a household cohort study in rural Kenya","volume":"209","author":"Munywoki","year":"2014","journal-title":"J Infect Dis."},{"key":"B98","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/infdis\/163.4.693","article-title":"Immunity to and frequency of reinfection with respiratory syncytial virus","volume":"163","author":"Hall","year":"1991","journal-title":"J Infect Dis."},{"key":"B99","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/infdis\/138.1.24","article-title":"The immunologic response to infection with respiratory syncytial virus in infants","volume":"138","author":"McIntosh","year":"1978","journal-title":"J Infect Dis."},{"key":"B100","doi-asserted-by":"publisher","first-page":"e1510","DOI":"10.1542\/peds.2007-1757","article-title":"Differential gender response to respiratory infectionsand to the protective effect of breast milk in preterm infants","volume":"121","author":"Klein","year":"2008","journal-title":"Pediatrics"},{"key":"B101","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/INF.0b013e31818a8a82","article-title":"Breastfeeding prevents severe disease in full term female infants with acute respiratory infection","volume":"28","author":"Libster","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"B102","doi-asserted-by":"publisher","first-page":"e303","DOI":"10.1542\/peds.112.4.e303","article-title":"Reduced risk of neonatal respiratory infections among breastfed girls but not boys","volume":"112","author":"Sinha","year":"2003","journal-title":"Pediatrics"},{"key":"B103","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1136\/bmj.299.6705.946","article-title":"Breast feeding and lower respiratory tract illness in the first year of life. Group Health Medical Associates","volume":"299","author":"Wright","year":"1989","journal-title":"BMJ"},{"key":"B104","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.earlhumdev.2018.10.003","article-title":"Predictors of hospitalization for acute lower respiratory infections during the first two years of life in a population of preterm infants with bronchopulmonary dysplasia","volume":"127","author":"Acu\u00f1a-Cordero","year":"2018","journal-title":"Early Hum Dev."},{"key":"B105","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1503\/cmaj.110754","article-title":"Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial","volume":"184","author":"Steinhoff","year":"2012","journal-title":"CMAJ"},{"key":"B106","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jinf.2017.08.008","article-title":"Assessment of clinical symptoms in household contacts of confirmed pertussis cases","volume":"75","author":"Dom\u00ednguez","year":"2017","journal-title":"J Infect"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1093\/cid\/cix497","article-title":"Efficacy of maternal influenza vaccination against all-cause lower respiratory tract infection hospitalizations in young infants: results from a randomized controlled trial","volume":"65","author":"Nunes","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B108","doi-asserted-by":"publisher","first-page":"e0152015","DOI":"10.1371\/journal.pone.0152015","article-title":"Clinical presentation and birth outcomes associated with respiratory syncytial virus infection in pregnancy","volume":"11","author":"Chu","year":"2016","journal-title":"PLoS ONE"},{"key":"B109","doi-asserted-by":"publisher","first-page":"e0148421","DOI":"10.1371\/journal.pone.0148421","article-title":"Burden of influenza and respiratory syncytial virus infection in pregnant women and infants under 6 months in mongolia: a prospective cohort study","volume":"11","author":"Chaw","year":"2016","journal-title":"PLoS ONE"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1093\/cid\/cix1091","article-title":"Respiratory syncytial virus during pregnancy","volume":"66","author":"Polack","year":"2018","journal-title":"Clin Infect Dis"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.3201\/eid2111.150497","article-title":"Maternal effects of respiratory syncytial virus infection during pregnancy","volume":"21","author":"Wheeler","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"B112","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1017\/S0950268814003793","article-title":"Relationship between meteorological conditions and respiratory syncytial virus in a tropical country","volume":"143","author":"Rodriguez-Martinez","year":"2015","journal-title":"Epidemiol Infect."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01006\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T09:09:44Z","timestamp":1694855384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01006\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,7]]},"references-count":112,"alternative-id":["10.3389\/fimmu.2019.01006"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01006","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,7]]},"article-number":"1006"}}